White House and Trump secure lower prices for obesity drugs and influence on international actions
TL;DR Summary
President Trump announced deals with Eli Lilly and Novo Nordisk to significantly reduce the out-of-pocket costs of weight loss drugs, including GLP-1 injections like Wegovy and Zepbound, with prices potentially dropping to as low as $50 to $350 per month depending on coverage and dosage, expanding access through Medicare, Medicaid, and direct-to-consumer platforms.
- Here's how much weight loss drugs could cost you under Trump's deals with Eli Lilly, Novo Nordisk CNBC
- Certain obesity drugs will cost as little as $149 and Medicare will start covering them under White House deals CNN
- Trump Announces Deal to Drop Obesity Drug Prices to as Little as $149 a Month The New York Times
- White House strikes deals for lower prices on obesity drugs NPR
- Trump says he was ‘very much in charge’ of Israel’s June 13 attack on Iran Al Jazeera
Reading Insights
Total Reads
1
Unique Readers
1
Time Saved
3 min
vs 4 min read
Condensed
92%
636 → 53 words
Want the full story? Read the original article
Read on CNBC